je.st
news
Tag: pharmaceuticals
King Pharmaceuticals settles over plant emissions
2013-06-29 03:20:22| Biotech - Topix.net
King Pharmaceuticals LLC has agreed to pay $2.2 million and comply with the Clean Air Act to resolve a complaint filed by federal prosecutors over emissions from its Bristol, Tenn., facility.
Tags: king
plant
emissions
pharmaceuticals
DelMar Pharmaceuticals to Present at the Conference
2013-06-26 20:49:08| Logistics - Topix.net
DelMar Pharmaceuticals, Inc. announced today that Jeffrey Bacha, president and CEO, will present at the 2013 OneMedForumNY Emerging Company Finance Conference on Thursday, June 27, 2013 in New York City at the Metropolitan Club.
Tags: present
conference
pharmaceuticals
delmar
Senesco Technologies, Inc. (SNT) - Pharmaceuticals & Healthcare -...
2013-06-20 15:11:07| Agriculture - Topix.net
The company researches and develops genetic technologies to improve commercial agriculture and to treat major medical conditions in humans.
Tags: technologies
healthcare
pharmaceuticals
snt
Tablet Counter supports solid-dose pharmaceuticals.
2013-06-20 14:29:16| Industrial Newsroom - All News for Today
Featuring servo-driven, GMP-compliant modular design, Cremer CFS-622 accommodates up to 4 counting modules to fill up to 170 bottles/min, based on 60-count bottles. System handles coated and uncoated tablets, capsules, or softgels ranging from 0.08–1.16 in. in length and 0.08–0.79 in. in diameter. In addition, machine can fill round, oval, and rectangular bottles that are 1.6–7.9 in. high and 0.08–4.9 in. in diameter. Tablet format can be changed in seconds via color touchscreen. This story is related to the following:Test and Measuring InstrumentsPackaging Products & EquipmentSearch for suppliers of: Pill, Tablet, Capsule & Caplet Counters |
Tags: counter
supports
tablet
pharmaceuticals
DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
2013-06-04 09:45:49| Logistics - Topix.net
Activity with VAL-083 Observed in Recurrent Malignant Glioma and Progressive Secondary Brain Tumors Company Plans to Expand Clinical Development of VAL-083 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.
Tags: data
additional
study
cancer
Sites : [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] next »